Ads
related to: biogen alzheimer's drug phase 3- Initiate Treatment
View Dosing & Administration Info
For An Approved Rx Option.
- Evaluate The MOA
View The Mechanism Of Action Video
And See Clinical Trial Results.
- Monitor For Safety
Review Important Safety Info And
Understand Infusion Reactions.
- Diagnose & Prepare
Learn To Diagnose Your Patients
With A Diagnostic Checklist.
- Support And Resources
Discover Coverage & Support Info
For Your Patients & Practice.
- Prescribing Information
See Safety & Full Prescribing Info
Including Boxed Warning.
- Initiate Treatment
Search results
FDA Approves Eli Lilly’s Alzheimer’s Drug
Barrons.com· 6 days agoAlzheimer’s Association estimates that 6.9 million people are living with the disease in the U.S. Investor enthusiasm for Alzheimer ...
FDA Approves Second Alzheimer’s Drug after Trial Shows it Can Slow Disease by 35%
The Daily Beast via Yahoo Canada News· 6 days agoThe Federal Drug Administration gave the go-ahead to a second Alzheimer’s treatment Tuesday after a...
The Zacks Analyst Blog Highlights Eli Lilly, Sanofi Merck, AstraZeneca's and Roche
Zacks via Yahoo Finance Canada· 17 hours agoRecap of the Week’s Most Important Stories FDA Approves Lilly’s Alzheimer’s Drug: The FDA granted...
FDA approves Kisunla for early Alzheimer's treatment amid cognitive decline slowdown
BioPharma-Reporter· 5 days agoIn the TRAILBLAZER-ALZ 2 phase 3 study, which included 1736 participants with early symptoms of ...
Ads
related to: biogen alzheimer's drug phase 3